Final Evidence Report and Meeting Summary

Multiple Sclerosis: Final Evidence Report

ICER’s final report on disease-modifying therapies for multiple sclerosis. The final report includes a summary of a February 2017 meeting of the California Technology Assessment Forum.

View All Materials on this Topic or Go Back to View More Materials